Reviews in Urology | |
Hemostasis During Urologic Surgery: Fibrin Sealant Compared With Absorbable Hemostat | |
Richard Kocharian2  Jerome B Riebman2  John Albanese2  Jessica Shen2  David M Albala1  Jonathan Batiller2  Bogdan Ilie2  Liza Ovington2  | |
[1] Associated Medical Professionals,, Syracuse, NY;Ethicon, Inc.,, Somerville, NJ | |
关键词: Hemostasis; Hemostatics; Fibrin tissue adhesive; Urologic surgical procedures; Surgical technique; | |
DOI : | |
学科分类:基础医学 | |
来源: MedReviews, LLC | |
【 摘 要 】
In the United States, fibrin sealants have been used to achieve hemostasis for nearly two decades. Although their clinical utility was first demonstrated in cardiac surgery, their effectiveness and safety have since been demonstrated to extend to a wide array of procedures. Fibrin sealants typically contain two components—fibrinogen and thrombin—that are combined and delivered simultaneously to a target bleeding site in order to achieve hemostasis. However, many commercial formulations contain other additional components, such as antifibrinolytic agents, that have been associated with adverse outcomes. This subanalysis compares the safety and effectiveness of a fibrin sealant versus an absorbable hemostat for achieving hemostasis during urologic procedures with mild to moderate bleeding.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912040560492ZK.pdf | 175KB | download |